---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-012084"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2023-02-15T23:59:59+00:00"
generated_at: "2026-06-19T11:12:14.820398+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma files provisional patent for CNS-homing peptides to treat Alzheimer's

## Summary
- Filed provisional patent for CNS-homing peptides targeting Alzheimer's disease and dementia.
- Peptides designed to reduce toxicity and improve therapeutic payload delivery to affected cells.
- CEO Eric Weisblum cited unmet need for effective Alzheimer's treatments and targeted delivery approach.
- Silo Pharma continues preclinical studies of novel therapeutics including psychedelic research.

## SEC filing metadata
- accession: 0001213900-23-012084
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2023-02-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390023012084/0001213900-23-012084-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390023012084/ea173740-8k_silopharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-012084
- JSON: https://secwatch.observer/filing/0001213900-23-012084.json
- Plain text: https://secwatch.observer/filing/0001213900-23-012084.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.